Dermira (DERM) Misses Q2 EPS by 15c

Dermira (NASDAQ: DERM) reported Q2 EPS of ($0.46), $0.15 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $14.8 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Wall Street scrambles to lift Micron price targets ahead of earnings
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS